Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
somatropine (rmc) 24 UI (8 mg), fiole de poudre et solvant pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin(rmc) |
Inferred relationship |
Some |
|
somatropine (rmc) 10 UI (3,33 mg), fiole de poudre et solvant pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin(rmc) |
Inferred relationship |
Some |
|
somatropine (rmc) 4 UI (1,33 mg), fiole de poudre et solvant pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin(rmc) |
Inferred relationship |
Some |
|
Product containing precisely somatropin(rmc) 1.33 milligram/1 vial powder for conventional release solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Somatropin(rmc) |
Inferred relationship |
Some |
1 |
Product containing precisely somatropin(rmc) 1.33 milligram/1 vial powder for conventional release solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Somatropin(rmc) |
Inferred relationship |
Some |
1 |
Product containing precisely somatropin(rmc) 3.33 milligram/1 vial powder for conventional release solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Somatropin(rmc) |
Inferred relationship |
Some |
1 |
Product containing precisely somatropin(rmc) 3.33 milligram/1 vial powder for conventional release solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Somatropin(rmc) |
Inferred relationship |
Some |
1 |
Product containing somatropin(rmc) in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin(rmc) |
Inferred relationship |
Some |
1 |
Product containing somatropin(rmc) (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin(rmc) |
Inferred relationship |
Some |
1 |
Product containing only somatropin(rmc) (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin(rmc) |
Inferred relationship |
Some |
1 |
Product containing only somatropin(rmc) in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Somatropin(rmc) |
Inferred relationship |
Some |
1 |